Principles with aims and areas | Transparency | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
AUSFTA | KORUS | TPP | AUSFTA | KORUS | TPP | ||||||
Pharmaceutical | 5 | Medical | 9 | Pharmaceutical | 5 | Pharmaceutical(s) | 9 | Reimbursement | 12 | Party | 20 |
Quality | 3 | Pharmaceutical | 8 | Medical | 5 | PBAC | 6 | Products | 12 | Proposed | 11 |
Innovative | 3 | Products | 7 | Products | 4 | Provide | 6 | Pharmaceutical | 11 | Agreement | 9 |
Health | 3 | Devices | 7 | Health | 4 | Listing | 5 | Medical | 11 | Regulation | 8 |
Procedure | 2 | Parties | 7 | Quality | 3 | Recommendations | 5 | Devices | 11 | Procedures | 8 |
Principles | 2 | Health | 5 | Public | 3 | Process | 4 | Pricing | 9 | Administrative | 8 |
Parties | 2 | Development | 4 | Importance | 3 | PBS | 4 | Regulations | 8 | Respect | 7 |
Committed | 2 | Care | 4 | Devices | 3 | Opportunity | 4 | Party | 8 | Provide | 7 |
Care | 2 | Access | 4 | Research | 2 | Information | 4 | Reasonable | 6 | Proceedings | 7 |
 |  | Quality | 3 | Procedure | 2 | Australia | 4 | Related | 5 | Information | 7 |
 |  | Patented | 3 | Principles | 2 | Application | 4 | Proposed | 5 | Review | 6 |
 |  | Generic | 3 | Parties | 2 | Reimbursement | 3 | Respecting | 4 | Reasonable | 6 |
 |  | Transparent | 2 | Including | 2 | Procedures | 3 | Period | 4 | National | 6 |
 |  | Safety | 2 | Development | 2 | Healthcare | 3 | Matter | 4 | Measures | 6 |
 |  | Research | 2 | Care | 2 | Federal | 3 | Level | 4 | Matter | 6 |
 |  | Promoting | 2 |  |  | Determinations | 3 | Including | 4 | Reimbursement | 5 |
 |  | Innovation | 2 |  |  | Applications | 3 | Government | 4 | Provided | 5 |
 |  | Incentives | 2 |  |  |  |  | Central | 4 | Official | 5 |
 |  | Improve | 2 |  |  |  |  | Application | 4 | Health | 5 |
 |  | Efficacy | 2 |  |  |  |  |  |  | Ensure | 5 |
 |  | Accountable | 2 |  |  |  |  |  |  | Comments | 5 |